Chronic liver and renal diseases differently affect structure of human serum albumin

被引:43
作者
Ivanov, AI
Korolenko, EA
Korolik, EV
Firsov, SP
Zhbankov, RG
Marchewka, MK
Ratajczak, H
机构
[1] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
[2] Polish Acad Sci, Inst Low Temp & Struct Res, Wroclaw, Poland
[3] Natl Acad Sci Belarus, B I Stepanov Inst Phys, Minsk 220072, BELARUS
关键词
infrared spectroscopy; Raman spectroscopy; conformational changes; uremia; cirrhosis;
D O I
10.1016/S0003-9861(02)00533-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human serum albumin (HSA) binding with endogenous metabolites and drugs is substantially decreased in chronic renal and liver diseases. To test the hypothesis that the decreased binding ability is caused by conformational changes of the protein, we analyzed infrared and Raman spectra of HSA isolated from healthy donors and patients with chronic uremia and liver cirrhosis. Uremia did not affect the secondary structure of HSA but modified the environment of its Asp/Glu residues. Liver cirrhosis increased the amount of extended and P-structures, modified the environment of Asp/Glu and Tyr side chains, and changed the configuration of disulfide bridges in albumin molecules. The conformational changes of "cirrhotic" albumin were not caused by reversibly bound ligands and resembled a partial unfolding of the protein induced by adsorption on the charcoal surface. The dramatic structural alterations of HSA in liver cirrhosis may be caused by its oxidative modification and might underlie the decreased binding ability and changed body distribution of albumin. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:69 / 77
页数:9
相关论文
共 61 条
  • [31] CONFORMATIONAL-CHANGES OF HUMAN SERUM-ALBUMIN INVIVO INDUCED BY FREE FATTY-ACIDS AS STUDIED BY FOURIER-TRANSFORM INFRARED-SPECTROSCOPY
    LEGAL, JM
    MANFAIT, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1041 (03) : 257 - 263
  • [32] LENKEI R, 1981, CLIN EXP IMMUNOL, V43, P381
  • [33] INHIBITION OF THYROXINE TRANSPORT INTO CULTURED RAT HEPATOCYTES BY SERUM OF NONUREMIC CRITICALLY ILL PATIENTS - EFFECTS OF BILIRUBIN AND NONESTERIFIED FATTY-ACIDS
    LIM, CF
    DOCTER, R
    VISSER, TJ
    KRENNING, EP
    BERNARD, B
    VANTOOR, H
    DEJONG, M
    HENNEMAN, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (05) : 1165 - 1172
  • [34] RAMAN STUDIES OF BOVINE SERUM-ALBUMIN
    LIN, VJC
    KOENIG, JL
    [J]. BIOPOLYMERS, 1976, 15 (01) : 203 - 218
  • [35] Lindup W., 1987, Progress in Drug Metabolism, V10, P141
  • [36] DISPLACEMENT BY ANIONIC DRUGS OF ENDOGENOUS LIGANDS BOUND TO ALBUMIN IN UREMIC SERUM
    MABUCHI, H
    NAKAHASHI, H
    [J]. THERAPEUTIC DRUG MONITORING, 1988, 10 (03) : 261 - 264
  • [37] MEUCCI E, 1991, J BIOL CHEM, V266, P4692
  • [38] Biophysical studies on the correction of uremic human serum albumin binding defects by in vitro charcoal adsorption treatment
    Nikolaev, V
    Sarnatskaya, V
    vonAppen, K
    Ivanov, A
    Rotellar, E
    Haspar, M
    Klinkmann, H
    [J]. ARTIFICIAL ORGANS, 1996, 20 (01) : 17 - 23
  • [39] Nikolaev V.G., 1992, ARTIFICIAL LIVER SUP, P197
  • [40] Niwa T, 1996, SEMIN NEPHROL, V16, P167